More than 4.2 million Americans live with glaucoma, a leading cause of vision loss in the nation. Although there is no cure for glaucoma, early detection and treatment can stop ...

This is a developing news story. Please check back soon for updates. Seonix Bio launched SightScore, a polygenic risk score ...

SightScore is a saliva test that looks at millions of genetic variants in the patient’s genome to create a personalized ...

The focus in recent years has shifted to reducing the long-term burden of medical therapy, minimizing the risk of medication ...

Voyager DSLT is indicated to perform SLT and is currently available in select markets in the E.U., the U.K. and now the U.S. The device adds to Alcon's glaucoma portfolio, which includes Hydrus ® ...

Researchers used mice with nine different genetic backgrounds to identify factors influencing eye aging, paving the way for eye-based diagnostics for neurodegenerative diseases.

Vision changes are an inevitable part of aging, but why are some more susceptible to age-related eye diseases and why do some individuals experience more severe decline than others?

Perceive Pharma Inc., a spin out from Perceive Biotherapeutics Inc., has closed a $15 million series A funding round to help ...

Glaucoma is a group of eye diseases that damage the optic nerve, which connects the eye to the brain. In most cases, glaucoma is caused by high pressure inside the eye. However, normal-tension ...

AI has demonstrated remarkable proficiency in diagnosing various eye diseases, including diabetic retinopathy, glaucoma, and ...

Glaucoma can affect one or both eyes, and some individuals with high eye pressure never develop it. Normal-tension glaucoma ...